Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Capital Expenditures: 2022-2023

Historic Capital Expenditures for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $42,000.

  • Lexeo Therapeutics' Capital Expenditures rose 68.00% to $42,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $115,000, marking a year-over-year change of. This contributed to the annual value of $481,000 for FY2024, which is 318.26% up from last year.
  • According to the latest figures from Q4 2023, Lexeo Therapeutics' Capital Expenditures is $42,000, which was up 121.05% from $19,000 recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Capital Expenditures high stood at $42,000 for Q2 2023, and its period low was $12,000 during Q1 2023.
  • Moreover, its 2-year median value for Capital Expenditures was $25,000 (2022), whereas its average is $28,000.
  • Data for Lexeo Therapeutics' Capital Expenditures shows a peak YoY spiked of 68.00% (in 2023) over the last 5 years.
  • Lexeo Therapeutics' Capital Expenditures (Quarterly) stood at $25,000 in 2022, then spiked by 68.00% to $42,000 in 2023.
  • Its Capital Expenditures was $42,000 in Q4 2023, compared to $19,000 in Q3 2023 and $42,000 in Q2 2023.